Results 111 to 120 of about 235,727 (237)

Exploring global and specific pathogenic mechanisms in Chronic Chagas Cardiomyopathy through multi-omics integration [PDF]

, 2023
Pauline Brochet, Jorge Kalil, Vincent Procaccio, Edécio Cunha‐Neto, Lionel Spinelli, Christophe Chevillard   +5 more
openalex   +1 more source

Chronic phase of Chagas disease: why should it be treated? A comprehensive review

Memorias do Instituto Oswaldo Cruz, 2011
The pathogenesis and evolutive pattern of Chagas disease suggests that the chronic phase should be more widely treated in order to (i) eliminate Trypanosoma cruzi and prevent new inflammatory foci and the extension of tissue lesions, (ii) promote tissue ...
José Rodrigues Coura, José Borges-Pereira   +1 more
doaj   +1 more source

Dysregulated Network of Immune, Endocrine and Metabolic Markers is Associated to More Severe Human Chronic Chagas Cardiomyopathy

Neuroimmunomodulation, 2018
Individuals who are infected with Trypanosoma cruzi develop chronic Chagas cardiomyopathy (CCC), which is a complication involving a series of immune pathogenetic mechanisms, although an association between immune and metabolic alterations was more ...
F. González, S. Villar, L. D'Attilio, R. Leiva, Julia Márquez, S. Lioi, J. Beloscar, O. Bottasso, A. Pérez   +8 more
semanticscholar   +1 more source

Proteomic inventory of myocardial proteins from patients with chronic Chagas' cardiomyopathy [PDF]

, 2006
Priscila Camillo Teixeira, Leo Kei Iwai, Andréia Kuramoto, R. Honorato, Alfredo Inácio Fiorelli, Noedir Antônio Groppo Stolf, Jorge Kalil, Edécio Cunha‐Neto   +7 more
openalex   +2 more sources

Effect of combined physical exercise program on improving the functional capacity and the cardiac autonomic modulation of Chagas cardiomyopathy [PDF]

, 2021
Diogo Van Bavel, Wallace Machado Magalhães de Souza, Yan de Britto Nery, Juliana Nascimento Amorin, Roberto Coury Pedrosa, Michel Silva Reis   +5 more
openalex   +1 more source

Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy

Scientific Reports, 2017
Chagas disease cardiomyopathy is a parasite-driven inflammatory disease to which there are no effective treatments. Here we evaluated the therapeutic potential of N,N-dimethylsphingosine(DMS), which blocks the production of sphingosine-1-phosphate(S1P ...
Juliana Fraga Vasconcelos, Cássio Santana Meira, Daniela Nascimento Silva, Carolina Kymie Vasques Nonaka, Pâmela Santana Daltro, Simone Garcia Macambira, Pablo Daniel Domizi, Valéria Matos Borges, Ricardo Ribeiro-dos-Santos, Bruno Solano de Freitas Souza, Milena Botelho Pereira Soares   +10 more
doaj   +1 more source

2025 ACVIM Forum Research Abstract Program

Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley   +1 more source

ISEV2025 Abstract Book

Journal of Extracellular Vesicles, Volume 14, Issue S1, October 2025.
wiley   +1 more source

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Pirfenidone Prevents Heart Fibrosis during Chronic Chagas Disease Cardiomyopathy [PDF]

Tatiana Araújo Silva, Diane Thomas, Jair L. Siqueira-Neto, Cláudia M. Calvet   +3 more
openalex   +1 more source